Recent studies show AI chatbots reduce anxiety in 68% of postpartum women, with startups like Maven Clinic securing $90M to expand tools. WHO endorses their role in low-resource regions, though ethica...
FDA-cleared AI tools now decode triple-negative breast cancer biomarkers in imaging scans, enabling earlier diagnosis and personalized therapies while raising ethical questions about algorithmic trans...
Oxford researchers demonstrate lifestyle and environment drive 70-80% of aging outcomes, with new epigenetic clocks and WHO data exposing accelerated aging in disadvantaged populations. Groundbreaking...
Emerging research and AI-driven tools are transforming gut health management, with new studies and startups challenging traditional approaches while raising ethical questions. Cutting-edge studies rev...
Moment for Parents’ CBT-based AI chatbot shows unprecedented results in treating perinatal mental health issues, addressing systemic care gaps through 24/7 accessible support. A July 2024 pilot ...
A breakthrough AI model accurately predicts lower-extremity amputation risks in diabetics using explainable machine learning, potentially reducing procedures by 85% through early interventions, per a ...
Chinese researchers discover key bioactive compounds and serum metabolites in Curcumae Kwangsiensis through advanced HPLC and molecular docking techniques, potentially revolutionizing TCM quality cont...
Breakthrough nano-encapsulation technology boosts curcumin and EGCG bioavailability by 300%, with clinical trials showing 45% skin elasticity improvement, signaling a new era in evidence-based anti-ag...
June 2024 research demonstrates prenatal PFAS exposure disrupts pancreatic beta cell function, increasing diabetes risk. EFSA slashes safety limits by 80% as EWG urges pregnancy precautions. Emerging ...
Exploring the controversial rise of BPC-157 peptide therapy for injury recovery amid conflicting preclinical evidence, regulatory warnings, and growing off-label use in athletics. A synthetic peptide ...
